Press Release | November 17, 2021
New Data Identifies Opportunity for Payers and Providers to Improve Diabetes Patient Care Through Enrollment in Remote Patient Monitoring (RPM) Programs
Get Closer To The Patient
With Data and Device Infrastructure for Remote Patient Monitoring and Chronic Care Management
100% Quality Guarantee1
1 – Smart Meter will replace any product not performing to specifications.
Get Closer To The Patient
With Data and Device Infrastructure for Remote Patient Monitoring and Chronic Care Management
100% Quality Guarantee1
1 – Smart Meter will replace any product not performing to specifications.
To celebrate National Diabetes Month, Smart Meter is offering FREE standard shipping on all iGlucose orders. Contact us today to learn more.
REDUCE PATIENT CHURN – FREE PROGRAM AVAILABLE NOW!
Talk to your account representative today to learn more.
Smart Meter is the foundation of the RPM Ecosystem
Smart Meter has propelled the industry forward with our full-suite of cellular-connected, FDA-approved devices and an innovative, robust data management portal for triaging patients and managing chronic conditions.
Smart Meter is the foundation of the RPM Ecosystem
Smart Meter has propelled the industry forward with our full-suite of cellular-connected, FDA-approved devices and an innovative, robust data management portal for triaging patients and managing chronic conditions.
Our Cellular-Connected Devices
iBloodPressure™
Now Available with an Extra-Large Cuff
iGlucose®
iScale™
Our Cellular-Connected Devices
Current Partners
Join the hundreds of market-leading RPM companies utilizing Smart Meter’s powerful cellular SmartRPM technology.
Smart Meter by the Numbers
300+
Distribution Partners
50,000+
Patients Monitored Daily
7.1m+
Patient Readings
99.9%
Device reliability2
Smart Meter by the Numbers
300+
Distribution Partners
50,000+
Patients Monitored Daily
7.1m+
Patient Readings
99.9%
Device reliability2
Cellular Remote Patient Monitoring:
Immediate. Reliable. Actionable.
Smart Meter eliminates the complex, extra steps—and delay—of sharing health metrics. All patients do is test by pressing a single button on iGlucose and iBloodPressure or simply stepping on the iScale. Clinicians benefit from access to cellular transmitted, real-time, reliable and secure patient data between visits, which can lead to better patient out comes.
Testimonials
"iGlucose’s ability to send BG data to our platform without syncing, pairing, home hubs or cables, is the perfect solution."– Joshua Claman, Former Chief Executive Officer, Rimidi
"Data flowing into the population management portal has quickly become an essential tool in managing diabetes for our patients. …iGlucose system drives better outcomes for our patients."– Joel Okner, MD, Cardiologist
"The iGlucose system with real-time data adds tremendous value to our diabetes education program ... The ability to have real-time data in making therapy decisions has been a huge plus."– Vivian N. Ayuk, PharmD, CDE, Chief Executive Officer, Flexcare Health Solutions
"Because of the remote patient monitoring available with your iGlucose meters, we will discuss the utility of remote patient monitoring for many patients. I can’t thank your company enough for enabling our future physicians an opportunity to gain an understanding of what they might ask of their future patients. "– Kathryn R Goldman, MD, Assistant Professor of Medicine, University of Connecticut School of Medicine
News + Events
New Data Identifies Opportunity for Payers and Providers to Improve Diabetes Patient Care Through Enrollment in Remote Patient Monitoring (RPM) Programs
Read More | November 17, 2021
Press Release | October 12, 2021
Smart Meter and Kardio Partner to Serve 500,000+ Ethnic Senior Patient Population in Greater Los Angeles Area
Smart Meter Launches Cellular-Enabled iScale™, Further Expanding the SmartRPM™ Remote Patient Monitoring (RPM) Platform
Read More | June 17, 2021
*Better Data. Better Care. Better Outcomes. Reference: Self-Monitoring of Blood Glucose: A Prerequisite for Diabetes Management in Outcome Trials Oliver Schnell, MD1, Markolf Hanefeld, MD2, and Louis Monnier, MD3
2 – 99.9% of active patients have zero product issues based on over 2 million clinical readings March – August 2021. Source: QA/RA Consulting Group.